RTALB.E — RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
TRY1.97bn
Enterprise Value
TRY2.08bn
Revenue
TRY239.56m

Annual balance sheet for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	R2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	163	246	148	14.4	10.5
Net Total Accounts Receivable
Net Total Receivables	158	165	66.2	95	107
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	369	511	360	203	185
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	46.8	167	211	375	389
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	552	1,343	1,805	2,515	3,434
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	205	146	128	282	134
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	240	279	188	330	469
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	313	1,064	1,617	2,185	2,965
Total Liabilities & Shareholders' Equity	552	1,343	1,805	2,515	3,434
Total Common Shares Outstanding